Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob Zhong

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|December 13, 2002
Evaluating qualitative assays using sensitivity and specificityBob Zhong
Contemporary Clinical Trials|July 17, 2012
Single-arm phase IIA clinical trials with go/no-go decisionsBob Zhong
Journal of Biopharmaceutical Statistics|March 15, 2003
Evaluating the agreement of two quantitative assays with repeated measurementsBob Zhong, Jun Shao
Journal of Biopharmaceutical Statistics|April 25, 2013
One-sample proportion testing procedures for hypothesis of inequalityWayne Zhong, Bob Zhong
Statistics in Medicine|July 23, 2003
Last observation carry-forward and last observation analysisJun Shao, Bob Zhong
Journal of Biopharmaceutical Statistics|March 19, 2004
Assessing the agreement between two quantitative assays with repeated measurementsJun Shaoi, Bob Zhong
Journal of Biopharmaceutical Statistics|January 31, 2006
On the treatment effect in clinical trials with dropoutJun Shao, Bob Zhong
Journal of Biopharmaceutical Statistics|February 4, 2015
A note on sequential monitoring of select-the-winner designK K Gordon Lan, Fei Chen, Bob Zhong, et al.
Targeted Oncology|June 15, 2014
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b studyIrene Brana, Antonio Calles, Patricia M LoRusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid TumorsRastislav Bahleda, Antoine Italiano, Cinta Hierro, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|December 13, 2002
Evaluating qualitative assays using sensitivity and specificityBob Zhong
Contemporary Clinical Trials|July 17, 2012
Single-arm phase IIA clinical trials with go/no-go decisionsBob Zhong
Journal of Biopharmaceutical Statistics|March 15, 2003
Evaluating the agreement of two quantitative assays with repeated measurementsBob Zhong, Jun Shao
Journal of Biopharmaceutical Statistics|April 25, 2013
One-sample proportion testing procedures for hypothesis of inequalityWayne Zhong, Bob Zhong
Statistics in Medicine|July 23, 2003
Last observation carry-forward and last observation analysisJun Shao, Bob Zhong
Journal of Biopharmaceutical Statistics|March 19, 2004
Assessing the agreement between two quantitative assays with repeated measurementsJun Shaoi, Bob Zhong
Journal of Biopharmaceutical Statistics|January 31, 2006
On the treatment effect in clinical trials with dropoutJun Shao, Bob Zhong
Journal of Biopharmaceutical Statistics|February 4, 2015
A note on sequential monitoring of select-the-winner designK K Gordon Lan, Fei Chen, Bob Zhong, et al.
Targeted Oncology|June 15, 2014
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b studyIrene Brana, Antonio Calles, Patricia M LoRusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid TumorsRastislav Bahleda, Antoine Italiano, Cinta Hierro, et al.
Pageof 2